Risk Assessment for HBV-Related Liver Cancer

Liver cancer is a severe disease worldwide. The incidence and mortality rates of liver cancer in China is the highest in the world. This project aims to perform a prospective, multi-center, large sample cohort study for HBV related high-risk individuals. Based on multimodal data fusion and AI technique, stratified management and follow-up system are conducted for HBV-related high-risk populations of liver cancer, in order to improve the early diagnosis rate of liver cancer.

NCT Number	NCT07160946
Lead Sponsor	Sun Yat-sen University
Conditions	HBV-related Liver Cirrhosis
Enrollment	6,000 participants
Start Date	2025-05-10
Primary Completion	2032-12-30 (estimated)
Study Completion	2032-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-08